Patrice Nordmann Selected Research

carbapenemase

12/2020	Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland.
1/2020	NitroSpeed-Carba NP Test for Rapid Detection and Differentiation between Different Classes of Carbapenemases in Enterobacterales.
1/2019	Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
10/2015	Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.
4/2014	Bloodstream infections caused by Pseudomonas spp.: how to detect carbapenemase producers directly from blood cultures.
1/2014	Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.
1/2014	New Delhi metallo-β-lactamase-producing Acinetobacter baumannii: a novel paradigm for spreading antibiotic resistance genes.
5/2012	Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
11/2006	Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrice Nordmann Research Topics

Disease

38	Infections 04/2022 - 03/2002
7	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 05/2003
4	Pneumonia (Pneumonitis) 01/2014 - 06/2002
3	Sepsis (Septicemia) 01/2017 - 09/2009
2	Community-Acquired Infections 12/2020 - 08/2007
2	Osteomyelitis 01/2019 - 05/2006
2	Enterobacteriaceae Infections 10/2017 - 04/2009
2	Bacteremia 01/2016 - 02/2012
2	Cross Infection (Nosocomial Infection) 08/2013 - 04/2007
2	Peritonitis 05/2012 - 11/2007
1	Healthcare-Associated Pneumonia 04/2022
1	COVID-19 11/2020
1	Critical Illness (Critically Ill) 01/2019
1	Bacterial Infections (Bacterial Infection) 10/2017
1	Opportunistic Infections (Opportunistic Infection) 01/2015
1	Wounds and Injuries (Trauma) 12/2013
1	Endocarditis 11/2013
1	Chronic Hepatitis B 01/2009
1	Burns 01/2005

Drug/Important Bio-Agent (IBA)

22	Carbapenems (Carbapenem Antibiotics)IBA 04/2022 - 06/2002
9	carbapenemaseIBA 12/2020 - 11/2006
9	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 01/2006
7	beta-Lactamases (beta-Lactamase)IBA 01/2019 - 06/2002
5	Colistin (Coly-Mycin)FDA Link 01/2021 - 03/2012
5	Ceftazidime (Fortum)FDA LinkGeneric 01/2014 - 03/2004
5	Imipenem FDA Link 02/2012 - 03/2002
4	LactamsIBA 03/2022 - 05/2012
4	EnzymesIBA 12/2011 - 07/2005
3	AminoglycosidesIBA 03/2022 - 08/2011
3	Polymyxins (Polymyxin)IBA 05/2021 - 01/2017
3	Meropenem (Merrem)FDA LinkGeneric 01/2017 - 04/2009
3	Doripenem FDA Link 01/2014 - 05/2011
3	beta-LactamsIBA 04/2009 - 06/2002
2	Fosfomycin FDA Link 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 10/2017 - 02/2009
2	Ertapenem (Invanz)FDA Link 01/2014 - 04/2009
2	Ciprofloxacin (Cipro)FDA LinkGeneric 10/2012 - 04/2006
2	Cefepime (Maxipime)FDA LinkGeneric 11/2007 - 03/2004
2	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 08/2007 - 03/2002
2	Cephalosporins (Cephalosporin Antibiotics)IBA 05/2003 - 03/2002
1	CefiderocolIBA 04/2022
1	oxacillinaseIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2019
1	plazomicinIBA 10/2017
1	Levofloxacin (Levaquin)FDA Link 01/2014
1	Aztreonam FDA LinkGeneric 01/2014
1	Vancomycin FDA LinkGeneric 11/2013
1	Daptomycin FDA Link 11/2013
1	oritavancinIBA 01/2013
1	FluoroquinolonesIBA 10/2012
1	CephalosporinaseIBA 05/2012
1	Tigecycline (Tygacil)FDA Link 03/2012
1	tRNA MethyltransferasesIBA 08/2011
1	Hepatitis B e AntigensIBA 01/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2009
1	adefovir dipivoxil (Hepsera)FDA Link 01/2009
1	Virulence Factors (Pathogenicity Factors)IBA 03/2008
1	IronIBA 03/2008
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 11/2007
1	2- methyl- 5- trimethylammoniummethyl- 1,3- oxathiolaneIBA 09/2006
1	TL 1IBA 05/2006
1	Norfloxacin FDA Link 04/2006
1	Cefotaxime (Kendrick)FDA LinkGeneric 03/2004
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 03/2004
1	Penicillins (Penicillin)FDA Link 05/2003

Therapy/Procedure

1	Therapeutics 03/2022
1	Salvage Therapy 01/2022
1	Drug Therapy (Chemotherapy) 04/2007